Carcinoma, Squamous Clinical Trials in Chicago, Illinois
2 recruitingChicago, Illinois
Showing 1–2 of 2 trials
Recruiting
Phase 2
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Carcinoma, Squamous CellAnorectal Cancer
University of Chicago35 enrolled1 locationNCT06669572
Recruiting
Phase 1
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
Head and Neck NeoplasmsNeoplasm MetastasisCarcinoma, Squamous Cell+3 more
University of Chicago36 enrolled1 locationNCT06912087